Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: A phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)

被引:0
|
作者
McGuire, WP
Hoskins, WJ
Brady, MF
Kucera, PR
Partridge, EE
Look, KY
ClarkePearson, DL
Davidson, M
机构
[1] EMORY UNIV, DEPT MED, ATLANTA, GA 30322 USA
[2] MEM SLOAN KETTERING CANC CTR, DEPT SURG, GYNECOL SERV, NEW YORK, NY 10021 USA
[3] CORNELL UNIV, COLL MED, DEPT OBSTET & GYNECOL, NEW YORK, NY USA
[4] ROSWELL PK CANC INST, GYNECOL ONCOL GRP, STAT OFF, BUFFALO, NY USA
[5] OREGON HLTH SCI UNIV, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, PORTLAND, OR 97201 USA
[6] UNIV ALABAMA, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, BIRMINGHAM, AL 35294 USA
[7] INDIANA UNIV, SCH MED, DIV OBSTET & GYNECOL, INDIANAPOLIS, IN USA
[8] DUKE UNIV, SCH MED, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, DURHAM, NC 27706 USA
[9] WALTER REED ARMY MED CTR, DEPT PATHOL & AREA LAB SCI, WASHINGTON, DC 20307 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [41] Re: "Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study"
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 279 - 280
  • [42] A randomized trial of cisplatin, vinblastine, and bleomycin versus cyclophosphamide, aclacinomycin, and cisplatin in epithelial ovarian cancer
    Tokuhashi, Y
    Kikkawa, F
    Tamakoshi, K
    Suganuma, N
    Kuzuya, K
    Arii, Y
    Hattori, SE
    Kobayashi, I
    Furuhashi, Y
    Nakashima, N
    Tomoda, Y
    ONCOLOGY, 1997, 54 (04) : 281 - 286
  • [43] Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study
    Thigpen, JT
    Brady, MF
    Homesley, HD
    Malfetano, J
    DuBeshter, B
    Burger, RA
    Liao, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3902 - 3908
  • [44] Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study
    Fleming, GF
    Brurietto, VL
    Cella, D
    Look, KY
    Reid, GCH
    Munkarah, AR
    Kline, R
    Burger, RA
    Goodman, A
    Burks, RT
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2159 - 2166
  • [45] Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: An interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group
    duBois, A
    Luck, HJ
    Meier, W
    Mobus, V
    Costa, S
    Richter, B
    Warm, M
    Bauknecht, T
    Schroder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 44 - 52
  • [46] A RANDOMIZED TRIAL COMPARING CISPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CANCER
    CONTE, PF
    BRUZZONE, M
    CHIARA, S
    SERTOLI, MR
    DAGA, MG
    RUBAGOTTI, A
    CONIO, A
    RUVOLO, M
    ROSSO, R
    SANTI, L
    CARNINO, F
    COTTINI, M
    MOSSETTI, C
    GUERCIO, E
    GATTI, M
    SILIQUINI, PN
    PRELATO, ML
    DURANDO, C
    GIACCONE, G
    CALCIATI, A
    FARININI, D
    CENTONZE, M
    RUGIATI, S
    PARODI, G
    MESSINEO, M
    STORACE, A
    BERNARDINI, G
    MISURALE, F
    ALESSANDRI, S
    CASINI, M
    RAGNI, N
    FOGLIA, G
    BENTIVOGLIO, G
    PESCETTO, G
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) : 965 - 971
  • [47] RANDOMIZED PHASE-III TRIAL OF CHEMO-IMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III AND STAGE-IV SUBOPTIMAL DISEASE OVARIAN-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    ALBERTS, DS
    MASONLIDDIL, N
    OTOOLE, RV
    ABBOTT, TM
    KRONMAL, R
    HILGERS, RD
    SURWIT, EA
    EYRE, HJ
    BAKER, LH
    GYNECOLOGIC ONCOLOGY, 1989, 32 (01) : 8 - 15
  • [48] A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE AND DOXORUBICIN WITH OR WITHOUT CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    OMURA, G
    BLESSING, JA
    EHRLICH, CE
    MILLER, A
    YORDAN, E
    CREASMAN, WT
    HOMESLEY, HD
    CANCER, 1986, 57 (09) : 1725 - 1730
  • [49] RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE PLUS CISPLATIN WITH OR WITHOUT DOXORUBICIN IN OVARIAN-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    OMURA, GA
    BUNDY, BN
    BEREK, JS
    CURRY, S
    DELGADO, G
    MORTEL, R
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 457 - 465
  • [50] A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study
    Homesley, Howard D.
    Filiaci, Virginia
    Gibbons, Susan K.
    Long, Harry J.
    Cella, David
    Spirtos, Nick M.
    Morris, Robert T.
    DeGeest, Koen
    Lee, Roger
    Montag, Anthony
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 543 - 552